About Index Trending news
Analyze
Pricing
Unum Therapeutics

Unum Therapeutics

Unum Therapeutics

Unum Therapeutics is a cellular therapeutics company ushering in a new wave in cancer immunotherapy.
I work here Suggest edits
More info

Elsewhere

Contributors to this profile

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy HubSpot HubSpot Mobile.co Mobile.co nuTonomy nuTonomy Biogen Biogen Hopper Hopper General Catalyst General Catalyst

Companies in the same industry

Lyncean Technologies Inc. Lyncean Technologies Inc. EdeniQ EdeniQ Frontier Biotechnologies Frontier Biotechnologies Wren Therapeutics Wren Therapeutics Cellestia Biotech Cellestia Biotech Congenica Congenica Atriva Therapeutics Atriva Therapeutics Silverback Therapeutics Silverback Therapeutics Aurora AR Aurora AR XTL Biopharmaceuticals Ltd. XTL Biopharmaceuticals Ltd.

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3
Add info
Add round
15 Mar 2017
$15,000,000
Debt financing
Square 1 Bank

Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank

FinSMEs
11 Jun 2015
$65,000,000
Venture capital (Series B)
Atlas Venture, Wellington Management, New Leaf Venture Partners, +9
21 Oct 2014
$12,000,000
Venture capital (Series A)
Atlas Venture, Fidelity Biosciences, Sanofi-Genzyme BioVentures